AI assistant
NextTrip, Inc. — Director's Dealing 2022
Feb 19, 2022
34837_dirs_2022-02-18_cf82a9e8-36ff-4b8f-b79a-8525910bde13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGMA LABS, INC. (SGLB)
CIK: 0000788611
Period of Report: 2022-02-16
Reporting Person: Brunsberg Jacob (President and COO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-16 | Stock Option (right to buy) | $2.50 | A | 70000 | Acquired | 2027-02-16 | Common Stock (70000) | Direct |
| 2022-02-16 | Stock Appreciation Right | $2.50 | A | 30000 | Acquired | 2027-02-16 | Common Stock (30000) | Direct |
Footnotes
F1: The stock option will vest and become exercisable in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.
F2: The stock appreciation right ("SAR") is payable in cash only, and will vest and become exercisable in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.